Cosmo Pharma 2025 Investor Day Report
    Research/Science 7/1/2025

    At a glance
    In this general discussion post, the primary subjects mentioned are the tone is 😐 neutral.

    Other terms

    Cosmo Pharma plans to release Breezula, a hair loss treatment, with expected FDA approval in 2027, but concerns arise over its high potential cost of $225/month. Users express skepticism about its effectiveness compared to cheaper alternatives like finasteride and minoxidil.
    View this post in the Community →

    Similar Community Posts Join

    5 / 225 results

    Related Research

    6 / 11 results